跳至主要内容
临床试验/NCT04443218
NCT04443218已完成不适用

Edwards PASCAL Transcatheter Valve Repair System Registry: A Multicenter Observational Registry With the Edwards PASCAL Transcatheter Valve Repair System

Edwards Lifesciences14 个研究点 分布在 2 个国家目标入组 220 人开始时间: 2019年5月27日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
220
试验地点
14
主要终点
Major Adverse Events (MAEs)

研究概览

简要总结

This registry will collect prospective and retrospective clinical data on patients treated with the Edwards PASCAL Transcatheter Valve Repair System outside of the Post-Market Clinical Follow-up (PMCF) study.

详细描述

Patients treated per standard of care at their medical facilities and a written informed consent will be collected to allow the data to be collected. This registry intends to enroll patients under commercial usage and will serve as a mechanism to collect clinical data to further characterize the safety, performance and effectiveness of the PASCAL Transcatheter Valve Repair System.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient signs informed consent to participate in the registry
  • Patient is intended to or has received the PASCAL device

排除标准

  • Patient does not consent to participate
  • Patient is part of an ongoing Edwards Pre or Post Market Clinical study for the PASCAL Transcatheter Valve Repair System.

结局指标

主要结局

Major Adverse Events (MAEs)

时间窗: 30 days

Composite rate of all-cause death, myocardial infarction, stroke, heart failure hospitalization, or complication requiring transcatheter or surgical intervention (repeat transcatheter edge-to-edge repair \[TEER\] or mitral valve surgery)

Mitral Regurgitation (MR) Reduction to <=2+

时间窗: 30 days, 12 months

MR severity assessed by sites using a 5-grade scale: none/trace (0-1+), mild (1+), mild to moderate (2+), moderate to severe (3+), and severe (4+).

次要结局

  • 6-Minute Walk Test (6MWT)(Baseline, 30 days, 12 months)
  • New York Heart Association (NYHA) Functional Classification(Baseline, 30 days, 12 months)
  • Quality of Life, as Assessed by Kansas City Cardiomyopathy Questionnaire (KCCQ) Overall Summary Scores(Baseline, 30 days, 12 months)
  • Quality of Life, as Assessed by EQ-5D Visual Analog Scale (VAS)(Baseline, 30 days, 12 months)

研究者

发起方
Edwards Lifesciences
申办方类型
Industry
责任方
Sponsor

研究点 (14)

Loading locations...

相似试验

Edwards PASCAL Transcatheter Valve Repair System... | 临床试验